Trice Medical™ was founded to fundamentally improve orthopedic diagnostics for the patient, physician, and payer by providing instant, eyes-on, answers. Trice has pioneered fully integrated camera-enabled technologies that provide a clinical solution that is optimized for the physicians office. Our mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system.

Platelet rich plasma / bone marrow concentrate

Innovative orthopaedic implants leveraging the power of 3D printing technology. Founded in May, 2015.

Our award winning Autologous Platelet Integrated Concentrate (APIC) System is a filtered plasma therapy process that concentrates the master protease inhibitor, Alpha-2-Macroglobulin (A2M). A2M binds to the enzyme protease to stop tissue degradation, as protease breaks down cartilage and is found in large quantities in joint spaces and discs. While A2M is found readily in our blood, it is too large to enter the joint or disc space and is not able to flush out the high presence of proteases causing degradation and pain for millions of patients. With the A2M Injection, patients can biologically “clean out” the joint and stop cartilage catabolism as well as prevent further degradation. Additionally, potential patient candidates can be verified by performing a Fibronectin-Aggrecan Complex Test (FACT) which determines the presence of FAC, a biomarker of cartilage catabolism, and predicts a positive functional outcome. For any OA grade 1, 2, or 3 patient, A2M should be the first regenerative medicine step, as you can perform a FAC test to determine if the patient is a good candidate. Animal studies for OA use are already complete (attached) as well as a 24 patient case series for DDD (attached) which helped the therapy secure one of Orthopedics This Week’s 2015 Best New Spine Technology spots. While the product has been FDA approved since 2014, our Phase II FDA approved, double-blinded, multisite, placebo controlled patient study for an OA indication started in June 2015 and APIC – A2M Injection· Alpha-2-Macroglobulin (A2M) Rich - 6 times the concentration found in blood

PERCUTANEOUS TENOTOMY AND PERCUTANEOUS FASCIIOTOMYThe innovative Tenex Health TX procedure is a gentle method for percutaneous cutting and removal of diseased tissue that causes Chronic Tendon Disease and aids in the restoration of natural tendon and soft tissue function. The Tenex Health TX System can be used to address the most common areas for tendon and soft tissue injuries including:Rotator cuffLateral and medial epicondylePatellar tendonAchilles tendonPlantar fasciaBased on technology developed in collaboration with the Mayo Clinic, the Tenex Health TX System combines conventional ultrasound imaging for visualization with the advanced TX™ MicroTip™ which utilizes ultrasonic energy to cut and debride diseased tendon tissue.

Regenerative Medicine/Wound Care